Login / Signup

CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer's disease-risk variant, SHARPIN G186R, reveal reduced NF-κB pathway and accelerated Aβ secretion.

Yuya AsanomiTetsuaki KimuraNobuyoshi ShimodaDaichi ShigemizuShumpei NiidaKouichi Ozaki
Published in: Journal of human genetics (2024)
Keyphrases